An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Drug Gaining Traction Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.
Learning About The Experimental Drug
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Experts Express Worries
However, physicians and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to individuals injecting substances of uncertain source.
Several experts stated the popularity for retatrutide could be linked to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.
Platform Reaction and Content Removal
According to TikTok, the service has taken down problematic material and banned associated hashtags and search suggestions. The company said it was dedicated to keeping the service secure and investing in strengthening enforcement strategies.
Digital Trading Operations
Investigations also found communities with up to nine thousand participants marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with images of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence.
Within minutes of entering one community, a seller shared contact information, where the majority of purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about weight, medical conditions or past usage.
Product Information and Pricing
Within these groups, messages display dark colored parcels with postal service stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A representative for the messaging service said it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her staff has already encountered patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose patients to possibly significant medical dangers”.
